TSX:WEED (Canopy Growth)
About WEED
Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.
Canopy Growth (TSX: WEED) Latest News
Investing
Why Quebec’s Plans for Cannabis Could Hurt Growth in the Industry

Investing
Is Canopy Growth Corp. a Buy at These Levels?

Investing
Why More Major Companies May Want a Weed Deal of Their Own With Canadian Marijuana Producers

Investing
Consolidation in the Marijuana Industry: Aurora Cannabis Inc. Wants to Acquire CanniMed Therapeutics Inc.

Investing
Why Investors Should Be Concerned About Canopy Growth Corp.’s Q2 Results
Investing
Why Dollarama Inc. Is a Better Buy Than Canopy Growth Corp.

Investing
Why Shorting Marijuana Stocks May Be the Best Trade of the Year

Investing
Ranking the Top 4 Canadian Marijuana Stocks
Investing
Better Growth Stock in 2018: Canopy Growth Corp. vs. Shopify Inc.
Investing
Are Canadian Marijuana Growth Stocks Safer to Own as Political Risks Gradually Fade?
Investing
Aurora Cannabis Inc. Surpasses $2 Billion!
